Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000078003-23-000013
Filing Date
2023-02-13
Accepted
2023-02-13 17:14:07
Documents
2
Group Members
PFIZER VENTURES (US) LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A PYXIS ONCOLOGY pyxis_13gx2x22fv.htm SC 13G/A 66053
2 EX-99.1 JOINT FILING AGREEMENT ex_991jointxpyxisx213.htm EX-99.1 6677
  Complete submission text file 0000078003-23-000013.txt   74352
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filed by) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 221-9059
Pyxis Oncology, Inc. (Subject) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92951 | Film No.: 23619902
SIC: 2834 Pharmaceutical Preparations